Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07483268
Eligibility Criteria:
Inclusion Criteria:
* Participants aged 18 years or older at the time of informed consent and provide voluntary informed consent to participate in the study before inclusion in the study.
* Physician decision to treat the participant with Stapokibart Injection for CRSwNP (according to the China-specific prescribing information) made prior to and independently of the participant's participation in the study.
Exclusion Criteria:
* Known history of allergic reaction to Stapokibart Injection.
* Participants currently or plan participating in any interventional clinical trial.
* Participants with hematologic malignancies.
* Women with pregnant.
* Any condition that, in the opinion of the Investigator, may interfere with the participant's ability to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07483268
Study Brief:
Protocol Section:
NCT07483268